周梦娇

师资介绍

周梦娇，女，汉族，1990年7月生，博士，讲师。

教育经历：

2014.09－2018.06，苏州大学，功能纳米与软物质研究院，材料科学与工程，博士

2011.09－2014.06，苏州大学，功能纳米与软物质研究院，材料科学与工程，硕士

2007.09－2011.06，苏州大学，材料与化学化工学部，材料科学与工程，学士

工作经历：

2018年至今，南通大学，药学院，讲师

2022.04－2023.04，香港城市大学，化学系，访问学者

研究方向：

功能性生物材料的设计；智能纳米药物的开发

基金项目：

1. 江苏省青年基金项目，江苏省科学技术厅，BK20200977，基于维生素B2的智能响应型纳米药物用于联合治疗的研究，2020-07至2023-06，20万元，结题

2. 南通市科技计划项目，南通市科学技术局，MS12018098，pH/氧化还原双重响应性的无载体纳米抗癌药物用于肿瘤靶向传递及协同治疗，2018-07至2020-06，10万元，结题

科研成果：

研究领域主要集中在设计开发智能纳米药物、研究其结构与性能关系等领域。在过去五年中，申请人主导或参与完成了多项重要的研究项目，并取得了一系列的学术成果：

近五年共发表SCI期刊论文10篇（Advanced Functional Materials、Journal of Controlled Release、International Journal of Pharmaceutic、Journal of Nanobiotechnology、European Journal of Medicinal Chemistry、Molecular Pharmaceutics、Nanomedicine: Nanotechnology, Biology and Medicine、Current Medicinal Chemistry、Biomedical Materials等），其中第一作者论文6篇；通讯作者论文3篇；参与编写出版英文专著1本（Elsevier）；授权专利1项。

代表性论文：

1. Meichen Zheng, Jingjing Zhang, Caiting Deng, Lei Chen, Heng Zhang, Jingqi Xin, Omer Aras,Mengjiao Zhou*, Feifei An*, Yu Ren*, The collaborated assembly of hydrophobic curcumin and hydrophilic cyanine dye into nanocolloid for synergistic chemo-photothermal cancer therapy.Materials & Design, 2024, 241: 112900.

2. Mengjiao Zhou; Minjian Yuan; Yilan Jin; Qianqian Zhou; Yuting Yu; Jianan Li; Xing Dai; Xiaohua Zheng; Haijun Yu; Weiqi Wang, Vitamin B2‐based ferroptosis promoter for sono‐enhanced nanocatalytic therapy of triple‐negative breast cancer.Advanced Functional Materials, 2023, 33(52): 2303899.

3. Yongmei Zhao; Yuanlin Zheng; Yan Zhu; Kai Ding;Mengjiao Zhou*; Tianqing Liu*, Co-delivery of gemcitabine and Triapine by calcium carbonate nanoparticles against chemoresistant pancreatic cancer.International Journal of Pharmaceutics, 2023, 636: 122844.

4. Yongmei Zhao; Tianqing Liu;Mengjiao Zhou*, Immune cell-derived exosomes for cancer therapy.Molecular Pharmaceutics, 2022, 19(9): 3042-3056.

5. Mengjiao Zhou; Minjian Yuan; Meng Zhang; Chenyi Lei; Omer Aras; Xiaohong Zhang; Feifei An, Combining histone deacetylase inhibitors (HDACis) with other therapies for cancer therapy.European Journal of Medicinal Chemistry, 2021, 226: 113825.

6. Jingqi Xin; Caiting Deng; Omer Aras;Mengjiao Zhou*; Chunsheng Wu*; Feifei An*, Chemodynamic nanomaterials for cancer theranostics.Journal of Nanobiotechnology, 2021, 19: 192.

7. Mengjiao Zhou; Xiao Liu; Fangmin Chen; Lili Yang; Minjian Yuan; Ding-Yi Fu; Weiqi Wang; Haijun Yu, Stimuli-activatable nanomaterials for phototherapy of cancer.Biomedical Materials, 2021, 16: 042008.

8. Mengjiao Zhou; Shupeng Han; Omer Aras; Feifei An, Recent advances in paclitaxel-based self-delivery nanomedicine for cancer therapy.Current Medicinal Chemistry, 2020, 28: 6358-6374.

9. Sena Karaosmanoglu;Mengjiao Zhou; Bingyang Shi; Xiujuan Zhang; Gareth R. Williams; Xianfeng Chen, Carrier-free nanodrugs for safe and effective cancer treatment.Journal of Controlled Release, 2020, 329: 805-832.

10. Mengjiao Zhou; Yuqi Xie; Shujun Xu; Jingqi Xin; Jin Wang; Tao Han; Richard Ting; Jie Zhang; Feifei An, Hypoxia-activated nanomedicines for effective cancer therapy.European Journal of Medicinal Chemistry, 2020, 195: 112274.

11. Mengjiao Zhou; Weijia Wei; Xianfeng Chen; Xiuzhen Xu; Xiaohong Zhang; Xiujuan Zhang, pH and redox dual responsive carrier-free anticancer drug nanoparticles for targeted delivery and synergistic therapy.Nanomedicine: Nanotechnology, Biology and Medicine, 2019, 20: 102008.

12. Mengjiao Zhou; Xiujuan Zhang; Xiuzhen Xu; Xianfeng Chen; Xiaohong Zhang, Doxorubicin@Bcl-2 siRNA core@shell nanoparticles for synergistic anticancer chemotherapy.ACS Applied Bio Materials, 2018, 1(2): 289-297.

13. Mengjiao Zhou; Xiujuan Zhang; Caitong Yu; Xueyan Nan; Xianfeng Chen; Xiaohong Zhang, Shape regulated anticancer activities and systematic toxicities of drug nanocrystals in vivo.Nanomedicine: Nanotechnology, Biology and Medicine, 2015, 12(1): 181-189.

14. Caitong Yu#;Mengjiao Zhou#; Xiujuan Zhang; Weijia Wei; Xianfeng Chen; Xiaohong Zhang, Smart doxorubicin nanoparticles with high drug payload for enhanced chemotherapy against drug resistance and cancer diagnosis.Nanoscale, 2015, 13(7): 5683-5690.

15. Mengjiao Zhou; Xiujuan Zhang; Yinlong Yang; Zhuang Liu; Baishun Tian; Jiansheng Jie; Xiaohong Zhang, Carrier-free functionalized multidrug nanorods for synergistic cancer therapy.Biomaterials, 2013, 34(35): 8960-8967.

16. Xiaojun Hao#;Mengjiao Zhou#; Xiujuan Zhang; Jia Yu; Jiansheng Jie; Caitong Yu; Xiaohong Zhang, Highly luminescent and photostable core-shell dye nanoparticles for high efficiency bioimaging. Chemical Communications, 2013, 50(6): 737-739.